213 related articles for article (PubMed ID: 34841436)
1. EGCG prevents pressure overload‑induced myocardial remodeling by downregulating overexpression of HDAC5 in mice.
Han X; Peng C; Huang L; Luo X; Mao Q; Wu S; Zhang H
Int J Mol Med; 2022 Jan; 49(1):. PubMed ID: 34841436
[TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin-3 gallate prevents pressure overload-induced heart failure by up-regulating SERCA2a via histone acetylation modification in mice.
Liu L; Zhao W; Liu J; Gan Y; Liu L; Tian J
PLoS One; 2018; 13(10):e0205123. PubMed ID: 30286210
[TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin-3-gallate attenuates cardiac hypertrophy in hypertensive rats in part by modulation of mitogen-activated protein kinase signals.
Chen DD; Dong YG; Liu D; He JG
Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):925-32. PubMed ID: 19298531
[TBL] [Abstract][Full Text] [Related]
4. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.
Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A
Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940
[TBL] [Abstract][Full Text] [Related]
5. Epigallocatechin gallate reverses cTnI-low expression-induced age-related heart diastolic dysfunction through histone acetylation modification.
Pan B; Quan J; Liu L; Xu Z; Zhu J; Huang X; Tian J
J Cell Mol Med; 2017 Oct; 21(10):2481-2490. PubMed ID: 28382690
[TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin-3-gallate (EGCG) Alters Histone Acetylation and Methylation and Impacts Chromatin Architecture Profile in Human Endothelial Cells.
Ciesielski O; Biesiekierska M; Balcerczyk A
Molecules; 2020 May; 25(10):. PubMed ID: 32429384
[TBL] [Abstract][Full Text] [Related]
7. Anacardic acid attenuates pressure-overload cardiac hypertrophy through inhibiting histone acetylases.
Li S; Peng B; Luo X; Sun H; Peng C
J Cell Mol Med; 2019 Apr; 23(4):2744-2752. PubMed ID: 30712293
[TBL] [Abstract][Full Text] [Related]
8. HDAC5 inhibition attenuates ventricular remodeling and cardiac dysfunction.
Zhu C; Piao Z; Jin L
Orphanet J Rare Dis; 2023 Sep; 18(1):266. PubMed ID: 37667300
[TBL] [Abstract][Full Text] [Related]
9. HDAC4 controls histone methylation in response to elevated cardiac load.
Hohl M; Wagner M; Reil JC; Müller SA; Tauchnitz M; Zimmer AM; Lehmann LH; Thiel G; Böhm M; Backs J; Maack C
J Clin Invest; 2013 Mar; 123(3):1359-70. PubMed ID: 23434587
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin gallate (EGCG) attenuates myocardial hypertrophy and fibrosis induced by transverse aortic constriction via inhibiting the Akt/mTOR pathway.
Cui Y; Wang Y; Liu G
Pharm Biol; 2021 Dec; 59(1):1305-1313. PubMed ID: 34607503
[TBL] [Abstract][Full Text] [Related]
11. SIRT6 mediated histone H3K9ac deacetylation involves myocardial remodelling through regulating myocardial energy metabolism in TAC mice.
Wu S; Zhang J; Peng C; Ma Y; Tian X
J Cell Mol Med; 2023 Nov; 27(22):3451-3464. PubMed ID: 37603612
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin gallate attenuates overload‑induced cardiac ECM remodeling via restoring T cell homeostasis.
Han Y; Wang Q; Fan X; Chu J; Peng J; Zhu Y; Li Y; Li X; Shen L; Asenso J; Li S
Mol Med Rep; 2017 Sep; 16(3):3542-3550. PubMed ID: 28713936
[TBL] [Abstract][Full Text] [Related]
13. Nicotinamide Riboside Alleviates Cardiac Dysfunction and Remodeling in Pressure Overload Cardiac Hypertrophy.
Ma S; Feng J; Lin X; Liu J; Tang Y; Nie S; Gong J; Wang L
Oxid Med Cell Longev; 2021; 2021():5546867. PubMed ID: 34567409
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin-3-gallate restores mitochondrial homeostasis impairment by inhibiting HDAC1-mediated NRF1 histone deacetylation in cardiac hypertrophy.
Li G; Pan B; Liu L; Xu X; Zhao W; Mou Q; Hwang N; Chung SW; Liu X; Tian J
Mol Cell Biochem; 2024 Apr; 479(4):963-973. PubMed ID: 37266748
[TBL] [Abstract][Full Text] [Related]
15. (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells.
Nandakumar V; Vaid M; Katiyar SK
Carcinogenesis; 2011 Apr; 32(4):537-44. PubMed ID: 21209038
[TBL] [Abstract][Full Text] [Related]
16. ANO1 relieves pressure overload-induced myocardial fibrosis in mice by inhibiting TGF-β/Smad3 signaling pathway.
Kong JC; Miao WQ; Wang Y; Zhou SF
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8493-8501. PubMed ID: 32894555
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechingallate attenuates myocardial injury in a mouse model of heart failure through TGF‑β1/Smad3 signaling pathway.
Chen K; Chen W; Liu SL; Wu TS; Yu KF; Qi J; Wang Y; Yao H; Huang XY; Han Y; Hou P
Mol Med Rep; 2018 Jun; 17(6):7652-7660. PubMed ID: 29620209
[TBL] [Abstract][Full Text] [Related]
18. Targeting E3 Ubiquitin Ligase WWP1 Prevents Cardiac Hypertrophy Through Destabilizing DVL2 via Inhibition of K27-Linked Ubiquitination.
Zhao D; Zhong G; Li J; Pan J; Zhao Y; Song H; Sun W; Jin X; Li Y; Du R; Nie J; Liu T; Zheng J; Jia Y; Liu Z; Liu W; Yuan X; Liu Z; Song J; Kan G; Li Y; Liu C; Gao X; Xing W; Chang YZ; Li Y; Ling S
Circulation; 2021 Aug; 144(9):694-711. PubMed ID: 34139860
[TBL] [Abstract][Full Text] [Related]
19. Repurposing Nintedanib for pathological cardiac remodeling and dysfunction.
Umbarkar P; Singh AP; Tousif S; Zhang Q; Sethu P; Lal H
Pharmacol Res; 2021 Jul; 169():105605. PubMed ID: 33965510
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin-3-gallate exerts cardioprotective effects related to energy metabolism in pressure overload-induced cardiac dysfunction.
Mou Q; Jia Z; Luo M; Liu L; Huang X; Quan J; Tian J
Arch Biochem Biophys; 2022 Jul; 723():109217. PubMed ID: 35427576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
